INSIGHTS Trademark

Trademark Overview

On Friday, February 9, 2024, a trademark application was filed for INSIGHTS with the United States Patent and Trademark Office. The USPTO has given the INSIGHTS trademark a serial number of 98400240. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, September 4, 2024. This trademark is owned by FRESENIUS MEDICAL CARE HOLDINGS, INC.. The INSIGHTS trademark is filed in the Medical Instrument Products and Computer & Software Services & Scientific Services categories with the following description:

Sensors connected to dialysis machines as well as sensors integrated into bloodlines for medical use to collect patient data; for assisting healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages

Cloud computing featuring software using patient data to assist healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages
insights

General Information

Serial Number98400240
Word MarkINSIGHTS
Filing DateFriday, February 9, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkIN SIGHTS
Goods and ServicesSensors connected to dialysis machines as well as sensors integrated into bloodlines for medical use to collect patient data; for assisting healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages
Goods and ServicesCloud computing featuring software using patient data to assist healthcare professionals with managing hemoglobin levels or managing anemia in End Stage Renal Disease and Chronic Kidney Disease patients by recommending optimized Erythropoietin Stimulating Agents drug dosages, including no dosage and iron dosages

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, February 9, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 9, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFRESENIUS MEDICAL CARE HOLDINGS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02451

Trademark Events

Event DateEvent Description
Friday, February 9, 2024NEW APPLICATION ENTERED
Monday, June 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 4, 2024ASSIGNED TO EXAMINER
Wednesday, September 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 4, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 4, 2024NON-FINAL ACTION E-MAILED

Related Keywords

insights managing disease dosages patients recommending kidney chronic optimized sensors erythropoietin